YOLFTbeta
Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

AUPH · NASDAQ · Healthcare / Biotechnology

15.73USD-0.48 (-2.96%)

Price History

Full chart

Market Stats

Previous Close16.21
Open16.27
Day Range15.72 – 16.27
52-Week Range10.34 – 19.25
Volume691.30K
Market Cap2.21B
P/E (TTM)7.28
Forward P/E11.83
EPS2.28
Dividend Yield0.00%
Beta1.41
50-Day Avg15.91
200-Day Avg15.54

About

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Kevin C. Tang
  • Employees128
  • Headquarters#140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6, USA
  • Websitehttps://www.auriniapharma.com

Leadership

  • Mr. Kevin C. TangChairman & CEO · b. 1967
  • Mr. Stephen P. RobertsonChief Legal Officer, Corporate Secretary & Chief Compliance Officer · b. 1982
  • Mr. Peter S. Greenleaf M.B.A.Consultant · b. 1970
  • Mr. Michael S. Hearne CPAChief Financial Officer · b. 1963
  • Mr. Ryan ColeChief Operating Officer · b. 1987
  • Mr. Thomas WeiChief Scientific Officer · b. 1976
  • Mr. Stewart M. KrollChief Development Officer · b. 1959

Financials

Income Statement

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue781.25K1.36M902.77K5.30M11.92M7.66M1.27M1.18M3.52M2.33M3.88M4.05M3.42M927.52K6.16M948.56K278.00K235.00K173.00K420.00K463.00K318.00K50.12M45.60M134.03M175.51M235.13M283.06M
Growth (%)-+73.85%-33.53%+486.77%+124.97%-35.71%-83.38%-7.51%+199.06%-33.72%+66.05%+4.52%-15.59%-72.88%+563.90%-84.60%-70.69%-15.47%-26.38%+142.77%+10.24%-31.32%+15660.38%-9.00%+193.89%+30.95%+33.97%+20.38%
Cost of Revenue520.83K679.10K680.66K1.03M686.01K1.45M1.60M2.06M597.12K1.05M2.12M575.88K50.99K185.11K46.24K939.1737.00K12.00K4.00K1.00K41.38M52.87M50.33M1.09M5.66M14.15M28.25M32.66M
Gross Profit260.42K679.10K222.11K4.27M11.23M7.66M1.27M1.18M2.93M1.28M1.76M3.48M3.37M742.41K6.11M947.62K241.00K223.00K169.00K419.00K-40.92M318.00K50.12M44.51M128.37M161.37M206.88M250.39M
Gross Margin33.33%50.00%24.60%80.65%94.24%100.00%100.00%100.00%83.05%55.02%45.44%85.79%98.51%80.04%99.25%99.90%86.69%94.89%97.69%99.76%-8837.80%100.00%100.00%97.61%95.77%91.94%87.99%88.46%
Operating Expense2.93M1.90M6.96M11.80M12.77M18.88M24.43M31.47M27.08M37.31M18.12M13.52M8.42M7.18M11.58M6.45M17.52M23.80M22.98M47.48M15.24M91.26M154.41M225.25M239.84M253.06M211.57M145.48M
Operating Income-2.67M-1.22M-6.74M-7.53M-1.54M-11.22M-23.16M-30.29M-24.15M-36.02M-16.36M-10.05M-5.05M-6.44M-5.47M-5.51M-17.28M-23.58M-22.81M-47.06M-56.16M-90.94M-104.29M-180.74M-111.47M-91.69M-4.69M104.91M
Operating Margin-341.67%-90.00%-746.61%-142.14%-12.95%-146.41%-1818.42%-2571.49%-685.66%-1543.04%-422.00%-247.91%-147.53%-694.19%-88.80%-580.40%-6216.55%-10034.04%-13187.28%-11205.48%-12129.16%-28598.43%-208.09%-396.31%-83.17%-52.24%-1.99%37.06%
EBITDA-1.95M-1.09M-6.33M-7.20M-861.96K-9.83M-20.83M-28.15M-22.60M-34.12M-14.22M-5.20M-4.26M-1.69M-8.94M-5.86M-15.70M-22.02M-21.34M-45.61M-53.93M-89.77M-102.92M-177.44M-108.76M-63.05M31.73M127.76M
EBITDA Margin-250.00%-80.00%-701.08%-135.89%-7.23%-128.29%-1635.73%-2390.13%-641.62%-1461.46%-366.72%-128.36%-124.69%-182.53%-145.12%-617.46%-5646.04%-9371.06%-12332.37%-10859.05%-11647.30%-28230.19%-205.35%-389.09%-81.15%-35.92%13.49%45.14%
Net Income-2.21M-1.22M-6.28M-7.40M-365.87K-14.65M-22.56M-29.08M-22.85M-33.82M-15.88M-7.60M-3.66M-2.41M-9.74M-2.55M-16.65M-18.61M-23.30M-70.79M-64.12M-88.39M-102.68M-180.97M-108.18M-78.02M5.75M287.20M
Net Income Margin-283.33%-90.00%-696.18%-139.78%-3.07%-191.17%-1771.39%-2468.42%-648.73%-1448.70%-409.67%-187.51%-107.02%-259.56%-158.13%-268.42%-5988.13%-7917.87%-13465.32%-16855.24%-13848.81%-27794.03%-204.88%-396.81%-80.71%-44.45%2.45%101.47%
R&D1.43M1.43M4.78M8.41M7.11M9.12M13.52M19.45M19.00M29.70M11.44M7.65M3.99M3.48M5.51M1.93M9.11M15.98M14.53M33.93M41.38M52.87M50.33M51.14M44.99M49.64M20.79M32.51M
R&D as % of Total Revenue183.33%105.00%529.29%158.76%59.63%119.08%1061.59%1650.88%539.48%1272.02%295.17%188.83%116.63%374.76%89.47%203.86%3277.70%6800.85%8401.16%8078.57%8937.80%16624.53%100.42%112.13%33.57%28.28%8.84%11.48%
Interest Expense0014.98K0034.70K0381.44K268.53K141.37K845.25K1.03M12.00K979.43101.03K103.00K30.00K50.00K27.00K702.00K2.23M39.00K5.29M529.00K5.12M2.77M4.83M4.33M
Interest Expense % of Total Revenue0.00%0.00%1.66%0.00%0.00%0.45%0.00%32.38%7.62%6.06%21.80%25.38%0.35%0.11%1.64%10.86%10.79%21.28%15.61%167.14%482.51%12.26%10.56%1.16%3.82%1.58%2.06%1.53%

Balance Sheet

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.56M4.14M13.97M37.06M50.68M74.43M61.17M54.35M30.64M42.67M26.66M9.55M10.28M14.32M4.16M23.14M52.38M33.57M57.00M189.85M145.86M324.30M463.66M543.37M470.86M548.06M550.64M751.59M
Total Liabilities2.41M950.74K1.21M1.78M3.12M5.89M8.97M11.99M10.47M14.25M18.79M4.74M3.93M7.91M6.28M9.84M7.27M13.60M21.05M24.10M33.29M25.70M55.91M64.28M65.42M170.11M173.17M170.26M
Total Equity-846.35K3.19M12.76M35.28M47.56M68.54M52.20M42.36M20.17M28.41M7.87M4.81M6.35M6.41M-2.12M13.30M45.11M19.96M35.95M165.74M112.58M298.60M407.75M479.09M405.44M377.95M377.48M581.33M
Cash-2.58M5.32M30.80M19.85M27.62M14.88M16.71M13.36M32.34M21.12M4.58M6.35M5.92M184.96K1.82M22.71M5.76M39.65M165.63M117.97M306.02M272.35M231.90M94.17M48.88M83.43M80.21M
Total Debt260.42K135.82K106.17K128.14K259.80K424.90K4.87M3.96M2.33M613.96K12.93M--79.33K36.19K1.32M------8.41M8.74M8.09M97.61M79.37M74.81M
Net Debt260.42K-2.44M-5.21M-30.67M-19.59M-27.20M-10.01M-12.74M-11.03M-31.72M-8.19M-4.58M-6.35M-5.84M-148.77K-501.17K-22.71M-5.76M-39.65M-165.63M-117.97M-306.02M-263.94M-223.16M-86.08M48.73M-4.06M-5.40M

Cash Flow

Currency: USD1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.76M-1.36M-5.77M-7.25M-849.90K-5.13M-20.15M-21.23M-21.03M-28.46M-17.39M-10.46M-4.34M-1.36M-6.55M-4.52M-16.90M-17.77M-18.71M-41.17M-51.61M-63.59M-69.86M-157.69M-79.53M-33.46M44.39M135.66M
Investing Cash Flow-65.10K-135.82K-7.25M2.51M-22.82M-14.41M979.92K7.33M19.02M9.23M-333.61K-163.31K1.48M-1.15M-31.16K-35.69K-10.08M-23.00K9.99M-8.00M-66.00K7.78M-158.19M-103.87M-60.63M-6.71M39.26M-32.77M
Financing Cash Flow1.56M4.21M15.89M30.41M12.38M24.62M4.87M15.26M-1.27M36.03M10.32M-9.61M4.64M2.28M716.71K6.21M47.89M839.00K42.62M175.15M4.01M243.85M194.38M221.11M2.43M-5.13M-49.09M-106.11M
Capital Expenditure130.21K0603.15K774.51K4.62M2.26M870.11K730.15K1.22M867.41K336.89K232.07K84.99K1.15M39.20K104.25K90.00K50.00K25.00K25.00K75.00K101.00K7.34M1.50M292.00K718.00K281.00K252.00K
Free Cash Flow-1.89M-1.36M-6.37M-8.02M-5.47M-7.39M-21.02M-21.96M-22.25M-29.33M-17.73M-10.69M-4.42M-2.51M-6.59M-4.63M-16.99M-17.82M-18.74M-41.19M-51.69M-63.69M-77.20M-159.19M-79.82M-34.18M44.11M135.41M
Dividends Paid--00000000000000------------
FCF to OCF107.41%100.00%110.46%110.69%644.10%144.02%104.32%103.44%105.81%103.05%101.94%102.22%101.96%184.90%100.60%102.30%100.53%100.28%100.13%100.06%100.15%100.16%110.51%100.95%100.37%102.15%99.37%99.81%
Dividend Paid to FCF--0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%------------

Earnings

Report DateNov 26, 2002Mar 11, 2003May 23, 2003Aug 25, 2003Nov 25, 2003Mar 29, 2004May 13, 2004Aug 10, 2004Nov 10, 2004Mar 2, 2005May 13, 2005Aug 9, 2005Nov 4, 2005Mar 14, 2006May 15, 2006Aug 3, 2006Nov 14, 2006Mar 16, 2007May 9, 2007Aug 14, 2007Nov 6, 2007Mar 18, 2008May 6, 2008Aug 6, 2008Nov 14, 2008Mar 27, 2009Nov 14, 2012May 16, 2013Aug 14, 2013Nov 22, 2013Mar 28, 2014May 16, 2014Aug 15, 2014Nov 12, 2014Mar 30, 2015May 15, 2015Aug 11, 2015Nov 13, 2015Mar 18, 2016May 11, 2016Aug 5, 2016Nov 4, 2016Mar 9, 2017May 15, 2017Aug 10, 2017Nov 14, 2017Mar 15, 2018May 10, 2018Aug 9, 2018Nov 8, 2018Mar 19, 2019May 14, 2019Aug 6, 2019Nov 14, 2019Mar 5, 2020May 14, 2020Aug 11, 2020Nov 10, 2020Feb 24, 2021May 6, 2021Aug 5, 2021Nov 3, 2021Feb 28, 2022May 10, 2022Aug 4, 2022Nov 3, 2022Feb 28, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Feb 15, 2024May 2, 2024Aug 1, 2024Nov 7, 2024Feb 13, 2025May 12, 2025Jul 31, 2025Nov 4, 2025Feb 26, 2026Apr 30, 2026Aug 6, 2026Nov 3, 2026
EPS Estimate0.00-2.00-3.003.00-3.75-3.50-4.00-3.25-6.00-6.50-7.00-6.50-3.00-4.57-6.50-4.00-4.50-4.83-4.75-4.50-4.83-4.50-4.00-2.50-2.50-2.00--------0.11-0.12-0.12-0.24-0.12-0.15-0.28-0.08-0.13-0.11-0.12-0.13-0.12-0.14-0.17-0.17-0.19-0.18-0.18-0.17-0.18-0.21-0.34-0.24-0.24-0.24-0.38-0.36-0.33-0.27-0.27-0.22-0.19-0.27-0.22-0.19-0.17-0.16-0.140.010.02-0.020.100.150.160.210.160.180.21
EPS Actual3.00-3.50-4.501.00-4.00-5.50-2.50-3.00-6.00-6.50-5.50-5.50-4.00-5.50-3.00-4.00-4.00-4.50-4.00-4.50-3.50-4.00-2.50-2.50-2.00-2.50-0.49-0.20-0.25-0.450.11-0.24-0.13-0.08-0.15-0.27-0.02-0.20-0.13-0.13-0.10-0.21-0.21-0.20-0.12-0.16-0.04-0.15-0.16-0.21-0.17-0.16-0.17-0.21-0.78-0.23-0.26-0.30-0.05-0.40-0.37-0.39-0.25-0.27-0.25-0.06-0.18-0.18-0.08-0.09-0.19-0.070.010.100.010.160.160.230.260.250.28-
Surprise--75.00%-50.00%-66.67%-6.67%-57.14%37.50%7.69%0.00%0.00%21.43%15.38%-33.33%-20.35%53.85%0.00%11.11%6.83%15.79%0.00%27.54%11.11%37.50%0.00%20.00%-25.00%-------27.27%-25.00%-125.00%91.67%-66.67%13.33%53.57%-25.00%-61.54%-90.91%-66.67%7.69%-33.33%71.43%11.76%5.88%-10.53%5.56%11.11%0.00%-16.67%-271.43%32.35%-8.33%-25.00%79.17%-5.26%-2.78%-18.18%7.41%0.00%-13.64%68.42%33.33%18.18%57.89%47.06%-18.75%50.00%0.00%400.00%162.50%60.00%6.67%43.75%23.81%56.25%55.56%-
Timing---------------------------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap2.21B
Enterprise Value1.84B
Trailing P/E7.28
Forward P/E11.83
PEG Ratio0.00
Price / Sales7.09
Price / Book3.61
EPS2.28
Book Value4.63
Revenue (TTM)311.51M
Gross Profit (TTM)242.61M
EBITDA179.83M
Profit Margin100.84%
Operating Margin55.69%
Return on Equity66.12%
Return on Assets15.49%
Shares Outstanding133.05M
Shares Float129.22M
Beta1.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 6 analystsTarget 17.86
  • Strong Buy
    3
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
60.44%
Insiders
6.70%
Retail / Other
32.86%

Top Institutional Holders

  • TANG CAPITAL MANAGEMENT LLC
    12.23M9.19%
  • BlackRock Inc
    7.85M5.90%
  • NEA Management Company, LLC
    3.97M2.98%
  • Two Sigma Investments LLC
    3.47M2.61%
  • Arrowstreet Capital Limited Partnership
    3.28M2.47%
  • State Street Corp
    2.53M1.90%
  • Morgan Stanley - Brokerage Accounts
    2.23M1.68%
  • Marshall Wace Asset Management Ltd
    1.87M1.41%
  • Renaissance Technologies Corp
    1.66M1.25%
  • Geode Capital Management, LLC
    1.54M1.15%
  • The Goldman Sachs Group Inc
    1.43M1.08%
  • D. E. Shaw & Co LP
    1.41M1.06%
  • Vanguard Portfolio Management, LLC
    1.26M0.94%
  • Jacobs Levy Equity Management, Inc.
    1.10M0.82%
  • Jupiter Asset Management Limited
    1.09M0.82%
  • LSV Asset Management
    1.08M0.81%
  • Nomura Holdings Inc
    978.60K0.74%

Top Fund Holders

  • iShares Russell 2000 ETF
    3.03M2.28%
  • Fidelity Small Cap Index
    1.29M0.97%
  • iShares Russell 2000 Growth ETF
    1.12M0.84%

Stock Splits

  • Oct 23, 20131:50